Context Therapeutics Inc. (CNTX)
NASDAQ: CNTX · Real-Time Price · USD
1.400
+0.260 (22.81%)
At close: Oct 9, 2025, 4:00 PM EDT
1.400
0.00 (0.00%)
Pre-market: Oct 10, 2025, 5:39 AM EDT
Context Therapeutics Market Cap
Context Therapeutics has a market cap or net worth of $125.59 million as of October 10, 2025. Its market cap has decreased by -14.57% in one year.
Market Cap
125.59M
Enterprise Value
42.24M
1-Year Change
-14.57%
Ranking
Category
Stock Price
$1.40
Market Cap Chart
Since the IPO on October 20, 2021, Context Therapeutics's market cap has increased from $51.03M to $125.59M, an increase of 146.11%. That is a compound annual growth rate of 25.45%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 9, 2025 | 125.59M | 33.33% |
| Dec 31, 2024 | 94.19M | 422.07% |
| Dec 29, 2023 | 18.04M | 73.39% |
| Dec 30, 2022 | 10.41M | -75.50% |
| Dec 31, 2021 | 42.46M | -16.78% |
| Oct 20, 2021 | 51.03M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 761.35B |
| Johnson & Johnson | 454.62B |
| AbbVie | 407.21B |
| UnitedHealth Group | 333.97B |
| AstraZeneca | 266.44B |
| Novo Nordisk | 261.01B |
| Novartis AG | 255.35B |
| Abbott Laboratories | 231.15B |